Aurinia Pharmaceuticals
AUPH
AUPH
78 hedge funds and large institutions have $194M invested in Aurinia Pharmaceuticals in 2019 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 18 increasing their positions, 19 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
6.51% more ownership
Funds ownership: 26.04% → 32.55% (+6.5%)
5% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 19
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
78
Holding in Top 10
–
Calls
$3.92M
Puts
$3.46M
Top Buyers
| 1 | +$27.4M | |
| 2 | +$20.5M | |
| 3 | +$2.37M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
+$2.1M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$1.93M |
Top Sellers
| 1 | -$3.22M | |
| 2 | -$2.72M | |
| 3 | -$1.84M | |
| 4 |
Franklin Resources
San Mateo,
California
|
-$1.47M |
| 5 |
Bank of Montreal
Toronto,
Ontario, Canada
|
-$444K |